250829 Gyeonggi Innovation Center Hosts the 32nd Startup 815 IR Alliance

250813 [Pharma Analysis] 16 Phase 3 Trials in July… Oncogenic Therapeutics & GNT Pharma Pursue Phase 3 for Expanded Indicat

250808 ICHEDAM Secures Approval for Phase 1 Clinical Trial of Herbal Degenerative Disease Drug Candidate

250806 Y&Archer Participates in ‘AFPRO 2025’… Showcasing Global Expansion Potential for Agri-Food Tech Startups

250806 Y&Archer Wraps Up ‘2025 Green Unicorn’ Investment Consultation

250804 “First Case of Korean Medicine Scientific Validation”… BICHEDAM’s Therapeutic Candidate Approved by MFDS

250803 Green Light for Global Drug Development Based on Korean Medicine

250731 BICHEDAM Secures Clinical Approval for Herbal Degenerative Disease Drug Candidate

250731 Korea Institute of Oriental Medicine Grants Clinical Approval for BICHEDAM’s Herbal Degenerative Disease Candidate